Compare Extra Space Storage, Inc. (EXR) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Extra Space Storage, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Extra Space Storage, Inc. trades at $134.5 (market cap $28.12B), while State Street SPDR S&P Biotech ETF trades at $153.75 (market cap $10.11B). The key difference: Extra Space Storage, Inc. is far larger — about 2.8× State Street SPDR S&P Biotech ETF's market cap, and Extra Space Storage, Inc. pays a 4.87% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Extra Space Storage, Inc. for 109 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| EXR | XBI | |
|---|---|---|
Market Cap | $28.12B | $10.11B |
Volume | 2,595,579 | 12,903,266 |
Sector | Real Estate | Broad Market / Factor |
52-Week High | $152.85 | $169.55 |
52-Week Low | $126.67 | $104.99 |
Typical Hold Time | 109 Days | 38 Days |
Enterprise Value | $41.84B | — |
Dividend Yield | 4.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EXR trades at $134.65, up 2.24% today, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected soon. Revenue grew to $3.38B in 2025, and net income margin stands at 27.79%. Analyst consensus is split evenly between Buy and Hold, with a price target of $158.33. Recent news highlights leadership transition and dividend declarations.
Outlook is balanced: solid operational performance and dividend yield support the stock, but high valuation ratios and bearish technicals pose near-term risks. Investors should weigh strong fundamentals against potential volatility from interest rate sensitivity and market sentiment shifts.
XBI trades at $153.75, up 2.34% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts like the Merck-Moderna cancer vaccine breakthrough.
Outlook remains mixed with 100% analyst hold rating contrasting with bullish news catalysts. Key risks include high volatility, sector-specific regulatory pressures, and expense ratios higher than broader healthcare ETFs. The current technical setup near resistance requires monitoring for breakout confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
